Supplement Firms' Cooperation With Trade Groups, Testing Labs Urged
This article was originally published in The Tan Sheet
Dietary supplement manufacturers should look upon industry trade associations as a vehicle for broad-based marketing of supplement ingredients' health benefits, a Nutrilite exec suggested at a Center for Business Intelligence seminar in Washington, D.C. April 18.
You may also be interested in...
FDA should build a "transparent basis for a new position on ephedra" by immediately releasing all new adverse event reports without an accompanying agency analysis, five dietary supplement industry groups say in a March 10 letter to Commissioner Jane Henney, MD. The agency also should "propose and make public in advance criteria for evaluation methods that will define the process that is appropriate for reviewing ephedra products in light of the new AERs and in the context of other necessary data, including consumption data," AHPA, CHPA, CRN, NNFA and UNPA say. On Feb. 25, FDA announced it was withdrawing the dosing and duration of use limits in its June 1997 proposed reg and would make publicly available all ephedrine alkaloid-related AERs received since the proposal's publication, along with an agency analysis of the AERs (1"The Tan Sheet" March 6, p. 9)
Dietary supplements making structure/function statements based on OTC monograph claims are not required to use the "Drug Facts" format to present material information covered under a monograph, FDA Associate Chief Counsel for Foods Louisa Nickerson said Feb. 16.
The various associations representing dietary supplement companies must step up their efforts to "work together in a cooperative, cohesive manner," Council for Responsible Nutrition President and CEO John Cordaro stated at the group's annual conference in Palm Springs, Calif. Oct. 3-6.